(Q35181958)

English

Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

cryopreservation

0 references

6

object named as

Kutluk Oktay

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Sanghoon Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sinan Ozkavukcu

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Elke Heytens

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Fred Moy

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Rose M Alappat

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

4 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Journal of Assisted Reproduction and Genetics

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

651-656

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

https://scigraph.springernature.com/pub.10.1007/s10815-011-9567-z

0 references

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Implementing a survivorship care plan for patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Cancer statistics, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Preliminary experience with orthotopic and heterotopic transplantation of ovarian cortical strips

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162058

28 July 2018

Trends in breast cancer by race and ethnicity: update 2006.

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Fertility preservation in young women undergoing breast cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Anti-Mullerian hormone (AMH): what do we still need to know?

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Anti-Müllerian hormone as a predictor of IVF outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

1 reference

https://api.crossref.org/works/10.1007%2FS10815-011-9567-Z

21 January 2018

High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21573682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10815-011-9567-Z

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

release_4gx5puszrrhyjabnuo4qcw5k5y

1 reference

https://api.fatcat.wiki/v0/release/4gx5puszrrhyjabnuo4qcw5k5y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35181958&oldid=1991889511"